{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:27:37Z","timestamp":1787113657030,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jfma.2026.08.015","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:24:14Z","timestamp":1786620254000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the efficacy of 14-day sequential therapy and 10-day bismuth quadruple therapy in the second line therapy for Helicobacter pylori infection- A multi-center randomized trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-4529","authenticated-orcid":false,"given":"Tsung-Hua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yuh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jyun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Horn","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yueh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-6883","authenticated-orcid":false,"given":"Chu-Kuang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-0647","authenticated-orcid":false,"given":"Hsiu-Chi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-004X","authenticated-orcid":false,"given":"Mei-Jyh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Ming","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6124-1964","authenticated-orcid":false,"given":"Yu-Jen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2026.08.015_bib1","first-page":"1","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"0","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2026.08.015_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2026.08.015_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/cancers11050593","article-title":"Efficacy and long term safety of H. pylori eradication for gastric cancer prevention","volume":"11","author":"Liou","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jfma.2026.08.015_bib4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2026.08.015_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12514","article-title":"Epidemiology of Helicobacter pylori infection","volume":"23","author":"Sjomina","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2026.08.015_bib6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jfma.2019.12.003","article-title":"Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan","volume":"119","author":"Fang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2026.08.015_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jfma.2026.08.015_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656566.2013.782286","article-title":"A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)","volume":"14","author":"Marin","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jfma.2026.08.015_bib9","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3748\/wjg.v18.i40.5669","article-title":"Levofloxacin\/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line","volume":"18","author":"Di Caro","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.015_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13712","article-title":"Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.015_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cgh.2014.10.036","article-title":"High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection","volume":"13","author":"Yang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2026.08.015_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ajg.2009.708","article-title":"Ten-day sequential therapy of Helicobacter pylori infection in Thailand","volume":"105","author":"Sirimontaporn","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2026.08.015_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori -A multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2026.08.015_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2026.08.015_bib15","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/jac\/dky183","article-title":"14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of helicobacter pylori: a multicentre, non-inferiority, randomized trial","volume":"73","author":"Liou","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.015_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4166\/kjg.2015.66.5.261","article-title":"[Ten-day sequential therapy versus bismuth based quadruple therapy as second line treatment for Helicobacter pylori infection","volume":"66","author":"Kim","year":"2015","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.jfma.2026.08.015_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183302","article-title":"Efficacy and safety of sequential versus quadruple therapy as send-line treatment for Helicobacter pylori infection \u2013 a randomized controlled trial","volume":"12","author":"Munteanu","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.015_bib18","first-page":"525","article-title":"Rescue therapies for H","volume":"10","author":"De Francesco","year":"2021","journal-title":"pylori Infection in Italy Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.015_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ueg2.12348","article-title":"Effectiveness of first and second-line empirical treatment in Italy: results of the European registry on Helicobacter pylori management","volume":"11","author":"Gatta","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jfma.2026.08.015_bib20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/archinte.165.13.1552","article-title":"A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan","volume":"165","author":"Wu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2026.08.015_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1751-2980.12367","article-title":"Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis","volume":"17","author":"Upala","year":"2016","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jfma.2026.08.015_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MEG.0000000000000774","article-title":"Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis","volume":"29","author":"Upala","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.015_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jgh.14462","article-title":"Systematic review and network meta-analysis: comparative effectiveness of therapies for second-line Helicobacter pylori eradication","volume":"34","author":"Yeo","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2026.08.015_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820976990","article-title":"Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan","volume":"13","author":"Liang","year":"2020","journal-title":"Therapeut Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.015_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ueg2.12348","article-title":"Effectiveness of first and second-line empirical treatment in Italy: results of the European registry on Helicobacter pylori management","volume":"11","author":"Gatta","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jfma.2026.08.015_bib26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2026.08.015_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jfma.2026.08.015_bib28","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s10620-019-05544-3","article-title":"Positive association between Helicobacter Pylori infection and metabolic syndrome in a Korean population: a multicenter national study","volume":"64","author":"Lim","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.jfma.2026.08.015_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2036.2002.01202.x","article-title":"Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen","volume":"16","author":"Elizakde","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jfma.2026.08.015_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3164\/jcbn.17-88","article-title":"Effects of Helicobacter pylori eradication on serum lipid levels","volume":"62","author":"Adachi","year":"2018","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.015_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/jcm10050904","article-title":"The effect of Helicobacter pylori eradication on lipid levels: a meta-analysis","volume":"10","author":"Watanabe","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.jfma.2026.08.015_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"et Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jfma.2026.08.015_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(21)00067-X","article-title":"Dramatic drop in new cancer drug trials during the COVID-19 pandemic","volume":"22","author":"Wilkinson","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.jfma.2026.08.015_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085906","article-title":"Completion and reporting of COVID-19 clinical trials registered on clinicalTrials.gov during the first 6 months of the pandemic: cohort study","volume":"14","author":"Tornhammar","year":"2024","journal-title":"BMJ Open"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462600803X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462600803X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:15:34Z","timestamp":1787112934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462600803X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S092966462600803X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.015","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the efficacy of 14-day sequential therapy and 10-day bismuth quadruple therapy in the second line therapy for Helicobacter pylori infection- A multi-center randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}